Blockchain Registration Transaction Record

Soligenix CEO Discusses Robust Pipeline and Strategic Milestones on BioMedWire Podcast

Soligenix CEO Dr. Christopher Schaber discusses the company's rare disease therapeutics focus, ongoing clinical trials, and innovative vaccine development on IBN's BioMedWire Podcast. Learn more about Soligenix's robust pipeline and government funding support.

Soligenix CEO Discusses Robust Pipeline and Strategic Milestones on BioMedWire Podcast

This news matters as it highlights Soligenix's innovative approach to rare disease therapeutics and vaccine development, showcasing the company's potential to address significant unmet medical needs. The discussion of near-term milestones and government funding demonstrates Soligenix's commitment to advancing healthcare solutions and its strategic positioning in the biopharmaceutical industry.

BlockchainDetails
Contract Address0x0553B273B8eBf464Bd2a37C259F0eEBb3d70Fd71
Transaction ID0xcb4f61f2088b299db86c11b15a8856de7f6035158c0ee1ac60d49fed2e793e24
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprintjoltwBbt-0641f1e76940edf5d4b7e106d2d747cc